LifeStance Health Group, Inc. (LFST)

NASDAQ

$6.92

+$0.01 (0.22%)

Today

No price data available for this timeframe.

Key Statistics

Day Range

$6.89$7.03

Open $6.97

52 Week Range

$3.74$8.29

Previous Close $6.91

Market Cap2.69B

Volume3.00M

Avg Volume1.93M

P/E (TTM)-293.71

EPS (TTM)$-0.02

Dividend / YieldN/A

Dividend StreakN/A

Analyst Ratings & Targets

Price Target

Consensus Target

$9.00

Based on 3 analysts (last year)

High Target

$10.00

Low Target

$8.00

Current

$6.92

Target

$9.00

$8.00$10.00

Potential upside of 29.96%

Based on consensus price target

Price Target Timeframes

Last Month

$9.00

2 analysts

Last Quarter

$9.00

2 analysts

Last Year

$8.83

3 analysts

All Time

$8.83

3 analysts

Analyst Consensus

Current Consensus

Buy

Based on 9 analyst ratings

Strong BuyBuyHoldSellStrong Sell

Stock Valuation Score

Rating:

(Score: 2)

DCFDiscounted Cash Flow - Evaluates fair stock value based on expected future cash flows1/5

ROEReturn On Equity - Measures profitability relative to shareholders' equity1/5

ROAReturn On Assets - Shows how efficiently a company uses its assets to generate profits1/5

D/E

Recent Price Target Updates

Date	Analyst	Firm	Target	Price	Upside
Dec 12, 2025	Unknown	BTIG	$10.00	$6.77	+47.71%
Dec 8, 2025	Peter Warendorf	Barclays	$8.00	$6.41	+24.80%
May 27, 2025	Kevin Caliendo	UBS	$8.50	$6.06	+40.26%

Recent Analyst Actions


Dec 12, 2025	Maintained	BTIG	Buy	Buy
Nov 7, 2025	Maintained	UBS	Buy	Buy
Nov 6, 2025	Maintained	BTIG	Buy	Buy
Aug 8, 2025	Maintained	UBS	Buy	Buy
May 27, 2025	Upgrade	UBS	Neutral	Buy

Showing 1 to 5 of 47 entries

Analyst Ratings & Targets

Price Target

Consensus Target

$9.00

Based on 3 analysts (last year)

High Target

$10.00

Low Target

$8.00

Current

$6.92

Target

$9.00

$8.00$10.00

Potential upside of 29.96%

Based on consensus price target

Price Target Timeframes

Last Month

$9.00

2 analysts

Last Quarter

$9.00

2 analysts

Last Year

$8.83

3 analysts

All Time

$8.83

3 analysts

Analyst Consensus

Current Consensus

Buy

Based on 9 analyst ratings

Strong BuyBuyHoldSellStrong Sell

Stock Valuation Score

Rating:

(Score: 2)

DCFDiscounted Cash Flow - Evaluates fair stock value based on expected future cash flows1/5

ROEReturn On Equity - Measures profitability relative to shareholders' equity1/5

ROAReturn On Assets - Shows how efficiently a company uses its assets to generate profits1/5

D/E

Recent Price Target Updates

Date	Analyst	Firm	Target	Price	Upside
Dec 12, 2025	Unknown	BTIG	$10.00	$6.77	+47.71%
Dec 8, 2025	Peter Warendorf	Barclays	$8.00	$6.41	+24.80%
May 27, 2025	Kevin Caliendo	UBS	$8.50	$6.06	+40.26%

Recent Analyst Actions


Dec 12, 2025	Maintained	BTIG	Buy	Buy
Nov 7, 2025	Maintained	UBS	Buy	Buy
Nov 6, 2025	Maintained	BTIG	Buy	Buy
Aug 8, 2025	Maintained	UBS	Buy	Buy
May 27, 2025	Upgrade	UBS	Neutral	Buy

Showing 1 to 5 of 47 entries